Stephanie Fisher
SelectQuoteAbout Stephanie Fisher
Stephanie Fisher, 48, is SelectQuote’s Chief Accounting Officer (CAO) and Principal Accounting Officer, a role she has held since August 2020; she was formally designated as principal accounting officer on June 1, 2022 . She previously served as CFO of YRC Worldwide (Yellow Corporation) and held senior accounting roles at YRC for over a decade; she began her career in Assurance at Ernst & Young. She holds a B.S. in Business Administration and a Master of Accountancy from Kansas State University . Company performance context: FY2025 revenue was ~$1.52B and Adjusted EBITDA ~$126.25M, underpinning management incentive frameworks; cumulative TSR from a fixed $100 investment was $12.36 in 2025, reflecting stock underperformance despite operational gains .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| SelectQuote, Inc. | Chief Accounting Officer; Principal Accounting Officer | Aug 2020–present; Principal Accounting Officer designated Jun 1, 2022 | Leads accounting, reporting integrity; principal accounting signatory on 10-Ks |
| YRC Worldwide (Yellow Corporation) | Chief Financial Officer | 2017 (CFO role noted) | Led strategic transformation of finance and operations |
| YRC Worldwide | Senior accounting roles (VP & Controller; Director of Financial Reporting) | Over a decade | Built controls, reporting, and accounting leadership |
| Ernst & Young LLP | Assurance | Not disclosed | Foundational audit and assurance experience |
External Roles
No public company directorships or external governance roles were disclosed for Fisher in SLQT filings (proxy/8‑K bios show none) .
Fixed Compensation
Stephanie Fisher was not a named executive officer (NEO) in FY2025; individual base salary, target bonus, and actual bonus amounts were not disclosed in the proxy CD&A (NEOs for FY2025 were Danker, Robert Grant, William Grant III, Clement, and Boulware) .
Performance Compensation
While Fisher’s specific incentive plan metrics and payouts were not disclosed, SLQT’s executive program used company-level financial goals (Revenue, Adjusted EBITDA, Operating Cash Flow) and equity awards. Company disclosed Price‑Vested Units (PVUs) for executives with multi‑tranche stock price hurdles; a PVU tranche vested across SLQT executive officers on February 26, 2025 (Forms 4 filed 2 days late), with shares surrendered for tax withholding—indicating in-kind vesting events and potential selling pressure associated with tax obligations .
Company PVU price hurdles (illustrative from disclosed plans):
| Grant Year | Tranche Price Hurdles | Vesting Structure |
|---|---|---|
| FY2025 executive plan | $3.13; $6.00; $9.00 (60‑day average price within 5‑year window) | Earned PVUs vest ratably in 3 annual installments from year 1 |
| FY2024 executive plan | $2.50; $5.00; $7.50; $10.00 (60‑day average price within 5‑year window) | Earned PVUs vest ratably in 3 annual installments from year 1 |
Note: Fisher’s specific grant sizes, hurdle attainment, and payout percentages were not disclosed. The February 26, 2025 PVU vesting was reported for “each of our executive officers,” which includes Fisher .
Equity Ownership & Alignment
- Anti‑hedging, anti‑short selling, and anti‑pledging policy: Executives (including Fisher) are prohibited from hedging, shorting, purchasing on margin, and pledging SLQT shares, except for narrow pre‑cleared exceptions—reducing misalignment and collateral risk .
- Section 16 reporting: Executive officers’ Forms 4 for PVU vesting (Feb 26, 2025) were filed two days late due to administrative error; reports included share surrenders for tax withholding, evidencing equity vesting mechanics and withholding‑driven dispositions .
- Beneficial ownership: Security ownership tables list directors/NEOs; Fisher’s specific share count and % outstanding were not disclosed (she is not a director and was not an FY2025 NEO) .
Employment Terms
- Role timeline: CAO since August 2020; principal accounting officer designation June 1, 2022 .
- Contract economics (severance/CoC): Not individually disclosed for Fisher. Company practice for NEOs includes double‑trigger severance and accelerated vesting under change‑in‑control, with no excise tax gross‑ups; these NEO terms may not apply to non‑NEO executives unless separately contracted .
- Compliance governance: Fisher is a principal accounting signatory on SLQT’s 10‑K filings (FY2022–FY2025), underscoring responsibility for financial reporting and controls .
Company Performance Context (FY2025)
| Metric | Target | Actual | % of Target |
|---|---|---|---|
| Revenue ($USD thousands) | $1,447,950 | $1,522,391 | 105% |
| Adjusted EBITDA ($USD thousands) | $106,388 | $126,220 | 119% |
Cumulative TSR (fixed $100 investment):
| Year | SLQT TSR ($) |
|---|---|
| 2025 | $12.36 |
Notable operating developments: healthcare services revenue growth, opening of a pharmacy fulfillment facility, securitization of commissions receivable ($100M), and $350M preferred equity financing with governance protections—forming the backdrop for accounting oversight and executive incentives .
Investment Implications
- Compensation alignment: Fisher’s specific cash/equity mix and performance metrics are not disclosed, but company‑wide executive incentives are anchored to revenue, Adjusted EBITDA, and cash flow, with PVUs tied to multi‑year stock price hurdles—aligning upside to shareholder returns .
- Selling pressure and vesting: The Feb 26, 2025 PVU vesting across executive officers (including Fisher) suggests periodic vest‑related share surrenders for taxes and potential ancillary selling pressure around vest dates; monitoring Section 16 filings near scheduled vesting is prudent .
- Alignment safeguards: Anti‑hedging/pledging rules reduce misalignment and collateralization risk; principal accounting officer role elevates Fisher’s accountability for financial reporting integrity—important for risk assessment in complex financing (ABS securitization, preferred stock terms) environments .
- Disclosure risk: Absence of individual compensation and ownership specifics limits pay‑for‑performance and skin‑in‑the‑game analysis at the executive level. Focus diligence on future proxies and Form 4 activity to refine retention risk and alignment views .